跳至主要内容
临床试验/NCT04606121
NCT04606121已完成不适用

The Benefit of Enhanced Day Care of Traditional Chinese Medicine: A Retrospective Study of Medical Records

Taipei City Hospital1 个研究点 分布在 1 个国家目标入组 401 人开始时间: 2020年6月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
401
试验地点
1
主要终点
scale of Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE)

研究概览

简要总结

We collected medical records since June 2017 to November 2019., used pair-T test for questionnaire of CTCAE, BFT-I, WHOQOL to evaluate the benefit of enhanced day care of TCM for cancer patients.

详细描述

using TCM method as Complementary and Alternative Medicine is worldwide. we collected medical records that using TCM methods for adverse event from cancer therapies. we used CTCAE BFI-T and WHOQOF-BREF to evaluate the benefit.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The medical records since June 2017 to December 2019 needed to meet the following criterial: (1)age>20 years old, (2)diagnosis meet ICD10:C00.0-C97 (3) needed to do Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE), scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T) and scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF), and those scales needed to be done pretest when patient came to the clinics and posttest when case end.

排除标准

  • The subjects will be excluded if they do not complete pretest and posttest of the following scales:(1) Taiwan brief version scale of CTCAE, (2) BFI-T scale (3) WHOQOL-BREF scale

结局指标

主要结局

scale of Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE)

时间窗: 2020

for chemotherapy related adverse effects in Taiwan

次要结局

  • scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T)(2020)
  • scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF)(2020)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验